Ultrasound-Enhanced Delivery of Compound TXA Solution in Melasma

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 20, 2025

Primary Completion Date

February 7, 2026

Study Completion Date

February 25, 2026

Conditions

Melasma (Facial Melasma)

Interventions

DEVICE

10%TXA+2%Reduced Glutathione applied via ultrasound at 5W/cm² in10min

5w/cm² Ultrasound-assisted topical application of 10% tranexamic acid and 2% reduced glutathione for 10 mins

OTHER

10%TXA+2%Reduced Glutathione applied via ultrasound at 0W/cm² 10min

topical application of 10% tranexamic acid and 2% reduced glutathione for 10 mins

Trial Locations (1)

The first Affiliated hospital with Nanjing medical university, Nanjing

All Listed Sponsors

lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT07202156 - Ultrasound-Enhanced Delivery of Compound TXA Solution in Melasma | Biotech Hunter | Biotech Hunter